Cure My Disease

Don't miss your cure!

 Log in / Sign up

Sound waves take on tough pancreatic cancer

NCT ID NCT05601323

Ongoing Disease control Sponsor: SONIRE Therapeutics Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding a special ultrasound device called Suizenji to standard chemotherapy helps people with advanced pancreatic cancer that didn't respond to initial treatment. About 90 adults whose cancer cannot be removed by surgery will receive either chemo alone or chemo plus the ultrasound treatment. The goal is to see if the combination improves survival and controls the disease better.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UNRESECTABLE PANCREATIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

exocrine pancreatic carcinoma malignant pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

UNRESECTABLE PANCREATIC CANCER

Contacts and locations

Locations

  • Aichi Medical University Hospital

    Nagakute-shi, Aichi, 480-1195, Japan

  • Kanagawa Cancer Center

    Yokohama-shi, Kanagawa, 241-8515, Japan

  • Tohoku University Hospital

    Sendai-shi, Miyagi, 980-8574, Japan

  • Tokyo Medical University Hospita

    Shinjuku-ku, Tokyo, 160-0023, Japan

  • Toyama University Hospital

    Toyama-shi, Toyama, 930-0194, Japan

  • Wakayama Medical University Hospital

    Wakayama-shi, Wakayama, 641-8510, Japan

  • Yokohama City University Medical Center

    Yokohama-shi, Kanagawa, 232-0024, Japan

More trials for these conditions

Other studies related to the condition(s) this trial covers.